Current Research in Translational Medicine

Papers
(The median citation count of Current Research in Translational Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFC23
Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation22
Performances of the H-score and the HLH-2004 score in the positive diagnosis of secondary hemophagocytic lymphohistiocytosis20
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era18
Lactate level is an independent predictor of mortality in patients with hematologic malignancy receiving urgent chemotherapy in intensive care unit16
Association of Normal and Mutated APOL1 G2 Rs60910145 alleles with SCD, Body Mass Index, and Renal Function Biomarkers and Indices15
Editorial board14
CRISPR-Cas9: a prominent genome editing tool in the management of inherited blood disorders and hematological malignancies12
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies11
A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis10
WITHDRAWN: Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetic body to induce macrophage polarization and inhibit erythrocyte damage9
Unusual expression of peripheral blood Alzheimer’s markers, inflammatory cytokines, and cholinergic biomarkers in chronic kidney disease patients with cognitive dysfunction: Therapeutic impact of reco9
Editorial board9
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis8
Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease8
Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports8
Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience8
Optimizing CAR-T cell function in solid tumor microenvironment: insights from culture media additives7
Editorial board7
Editorial board7
CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis7
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation7
AI-assisted computational screening and docking simulation prioritize marine natural products for small-molecule PCSK9 inhibition6
Editorial board6
mRNA-lncRNA gene expression signature for predicting pediatric AML relapse6
Efficacy and safety of Venetoclax combined with Azacitidine in the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - a single-center retrospective6
Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation6
Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization6
Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH)5
Thanks to reviewers5
Contents5
The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials5
Contents5
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization a5
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantati5
Impact of the rest period between sequential chemotherapy and conditioning regimen prior to allogeneic hematopoietic stem cell transplantation for high-risk myeloid malignancies5
Exosomal miR-195 in hUC-MSCs alleviates hypoxia-induced damage of trophoblast cells through tissue factor pathway inhibitor 24
Letter to the editor regarding “Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: A systematic review and meta-analysis”4
Exploring clues pointing toward the existence of a brain-gut microbiota-hair follicle axis4
Attenuated Salmonella as a PD-1/PD-L1 SiRNA delivery system for colorectal cancer, hepatocellular carcinoma, and melanoma: A systematic review4
CD28 pathway blockade to transplant tolerance: Expanding the landscape of immune regulation4
A systematic review of published clinical studies using cell-derived extracellular vesicles: A focus on efficacy in COVID-19 and wound healing4
Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review4
Real-world treatment and long-term outcomes after autologous stem cell transplantation in first line for myeloma in France and Algeria before the daratumumab era4
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression4
Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells4
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)4
Editorial board3
Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Digital pathology and artificial intelligence in the era of modern slides: A state of the art3
Editorial board3
Allogeneic hematopoietic stem cell transplantation in 18 patients with atypical inherited bone marrow failure syndromes: Efficacy and long-term outcomes3
Optimized GMP-grade Wharton’s jelly’s mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease prevention3
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations3
Caspases in PANoptosis3
Successful treatment of congenital sideroblastic anemia with low-dose decitabine in a patient with NDUFB11 gene mutation (c.276_278del): A case report3
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set3
Contents3
Editorial board3
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia3
Clinical image: A new category of articles in current research in translational medicine3
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice3
Thanks to reviewers3
The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical a3
Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus3
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine2
An updated meta-analysis of umbilical cord blood to treat cerebral palsy: distinguishing cord blood infusions from mesenchymal stromal cell therapy2
Are we there yet? cellular therapies for cutaneous T cell lymphoma2
Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights2
AML-derived extracellular vesicles negatively regulate stem cell pool size: A step toward bone marrow failure2
Acute-onset chronic inflammatory demyelinating polyneuropathy in a 23-year-old male exacerbated by an asymptomatic COVID-19 infection2
IL-10+ regulatory B lymphocytes are impacted by intradermal PBMCs therapy in patients with unexplained recurrent pregnancy loss (uRPL)2
Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)2
Biochemical pancreatic β-cell lineage reprogramming: Various cell fate shifts2
Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)2
Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation2
Enhancing Alzheimer's disease prediction using random forest: A novel framework combining backward feature elimination and ant colony optimization2
Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice2
Editorial board1
CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report1
Advances in the relationship of immune checkpoint inhibitors and DNA damage repair1
Preclinical evidence of anti-CD19 CAR-T cell in vitro and in vivo efficacy against CD19-expressing acute myeloid leukemia1
Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia✰,✰✰1
Expert consensus on the management of cytomegalovirus infection in pediatric allogeneic hematopoietic stem cell transplantation1
Autologous intraarterial pancreatic bone-marrow mononuclear cells infusion in T2D patients: Changes on beta-cells function, insulin resistance, and inflammatory marker1
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura1
Contents1
Oral CXCR4 inhibition with mavorixafor: Emerging therapeutic applications in WHIM syndrome, chronic neutropenia, oncology, and stem cell mobilization1
The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing1
Effect of adipose-derived mesenchymal stromal/stem cells on mouse mammary tumour growth and formation of lung metastases1
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?1
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience1
Infections in VEXAS syndrome: a systematic review of the literature1
Effect of AML-exosomes on the cellular and molecular properties of bone marrow mesenchymal stromal cells: Expression of JAK/STAT signaling genes1
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management1
Role of IGF2BP3 as a prognostic biomarker in chronic myeloid leukemia progression and disease stratification1
IDH1 mutation in acute lymphoblastic leukemia—A rare but significant finding1
Variability in expression of homeobox genes (HOXA9) and (HOXA7) in acute myeloid leukemia patients1
Clinical features and functions of a novel Lpl mutation C.986A>C (p.Y329S) in patient with hypertriglyceridemia1
CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma1
Identifying potential prognosis markers in relapsed multiple myeloma via integrated bioinformatics analysis and biological experiments1
Two years of COVID-19: A summary about the implication of current research in translational medicine in the efforts against the pandemic1
Editorial board1
Sexual and emotional life among patients with hematological malignancy—Special concerns in low- and middle- income countries (LMICs)1
Contents1
Establishing hemoglobin A, F, A2 reference intervals in neonatal cord blood and clinical decision values for β-thalassemia genetic testing1
A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management1
In vivo and in vitro effects of cord blood hematopoietic stem and progenitor cell (HSPC) expansion using valproic acid and/or nicotinamide1
Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media1
In vitro blood brain barrier models: Molecular aspects and therapeutic strategies in glioma management1
Generalized skeletal sclerosis as a potential late effect of total body irradiation after allogeneic hematopoietic stem cell transplantation: A case report1
Explainable AI for Parkinson’s disease prediction: A machine learning approach with interpretable models1
A comprehensive review on artificial intelligence driven approaches for vaccine development: Current advances, challenges, and future prospects1
A novel complex mutation affecting two codons in the exon 10 hotspot region of the MPL gene1
Lipid nanoparticle mediated delivery of Anti-CD19 CAR mRNA to umbilical cord blood NK cells for targeting CD19⁺ primary B-ALL cells1
0.2215371131897